NRx Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Business Update
Financial Results
NRx Pharmaceuticals, Inc. today announced its financial results for the third quarter of 2022 and provided a business and clinical update.
NRx Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2022 and provided a business and clinical update.
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, NRx Pharmaceuticals), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter ended March 31, 2022 and provided a business and clinical update.
NRx Pharmaceuticals, Inc. today announced its financial results for the year ended December 31, 2021 and provided a business update.